Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

10x Genomics (TXG) Inventory Average (2019 - 2025)

Historic Inventory Average for 10x Genomics (TXG) over the last 7 years, with Q4 2025 value amounting to $59.1 million.

  • 10x Genomics' Inventory Average fell 3322.48% to $59.1 million in Q4 2025 from the same period last year, while for Dec 2025 it was $59.1 million, marking a year-over-year decrease of 3322.48%. This contributed to the annual value of $69.7 million for FY2025, which is 1107.37% down from last year.
  • Per 10x Genomics' latest filing, its Inventory Average stood at $59.1 million for Q4 2025, which was down 3322.48% from $65.5 million recorded in Q3 2025.
  • 10x Genomics' 5-year Inventory Average high stood at $91.2 million for Q3 2024, and its period low was $34.2 million during Q1 2021.
  • For the 5-year period, 10x Genomics' Inventory Average averaged around $70.3 million, with its median value being $76.0 million (2022).
  • Per our database at Business Quant, 10x Genomics' Inventory Average skyrocketed by 10314.87% in 2021 and then crashed by 3322.48% in 2025.
  • Over the past 5 years, 10x Genomics' Inventory Average (Quarter) stood at $55.6 million in 2021, then skyrocketed by 44.24% to $80.1 million in 2022, then decreased by 3.52% to $77.3 million in 2023, then grew by 14.57% to $88.6 million in 2024, then crashed by 33.22% to $59.1 million in 2025.
  • Its last three reported values are $59.1 million in Q4 2025, $65.5 million for Q3 2025, and $71.8 million during Q2 2025.